Rising Private Credit Defaults Pose Challenges for Banks and Insurers The Fight Against Foreign Developers Buying Caribbean Beaches Implications for Tourism and Real Estate US GDP Growth Revised Downward to 16 Annualized Rate in Q1 Bitcoin LongTerm Holder Supply Approaches Record 163 Million BTC as Smart Money Accumulates RealWorld Gaming Industry Gains Momentum as Consumers Seek Shared Experiences and Escapism CURR Q3 2025 Earnings Stunning EPS Beat Fuels Share Rally Taylor Morrison Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Purple Biotech Ltd PPBT Q1 2025 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances SERV Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty CHEF Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Despite Stock Pullback Gesher Acquisition Corp II GSHR Shares Inch Higher as SPAC Hovers Near Trust Value MSC Industrial Direct MSM Edges Lower Amid Industrial Sector Headwinds SolGel Technologies SLGL Retraces 291 as Shares Approach Key Support Level DoubleDown Interactive DDI Slips 1 as Stock Tests Support Zone Southern Company SO Holds Near Support Amid Modest Decline Blackrock MuniYield Michigan Quality Fund MIY Edges Higher Amid Steady Trading Chip Companies Turn to Photonics to Tackle AI Data Transfer Bottleneck WLYB Q1 2026 Earnings EPS Surpasses Estimates by 1167 Stock Dips 144 Rising Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Finds SpaceX Faces Crucial Launch Test as IPO Speculation Intensifies MTRN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 234 Enova International Inc ENVA Pulls Back 21 Support Test Could Define NearTerm Trend Vistagen Therapeutics VTGN Shows Modest Gain Amid Tight Trading Range CCLDO Preferred Shares Hold Steady at 2744 as Fixed Income Dynamics Support Stability Motorsport Games Inc MSGM Declines 586 as Support Near 397 Faces Retest Allegiant Travel ALGT Soars 858 on Positive Momentum Key Levels to Watch ALPS Group Holds Above 070 Support After Modest Uptick Cosmos Health COSM Slips to 026 Testing Key Support Amid Downside Pressure Silexion Therapeutics SLXN Slips 3 as Shares Test Key Support at 040